Evidence map›Paper›PMID 41516174›Full record

ArticleInternational journal of molecular sciences2025

A Simple Restriction Fragment Length Polymorphism-Based Method for Multiplex Testing of Thrombosis Risk Factors FV Leiden and

Philippe de Mazancourt, Sylvie Grey, Elise Alabre, Mariam Keita, Jean-Pierre Rabès

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Philippe de MazancourtLaboratory of Biochemistry and Molecular Genetics, Ambroise Paré Hospital, GHU APHP-Université Paris-Saclay, F-92100 Boulogne-Billancourt, France.ORCID 0000-0001-8091-9882
Sylvie GreyLaboratory of Biochemistry and Molecular Genetics, Ambroise Paré Hospital, GHU APHP-Université Paris-Saclay, F-92100 Boulogne-Billancourt, France.
Elise AlabreLaboratory of Biochemistry and Molecular Genetics, Ambroise Paré Hospital, GHU APHP-Université Paris-Saclay, F-92100 Boulogne-Billancourt, France.
Mariam KeitaLaboratory of Biochemistry and Molecular Genetics, Ambroise Paré Hospital, GHU APHP-Université Paris-Saclay, F-92100 Boulogne-Billancourt, France.
Jean-Pierre RabèsLaboratory of Biochemistry and Molecular Genetics, Ambroise Paré Hospital, GHU APHP-Université Paris-Saclay, F-92100 Boulogne-Billancourt, France.ORCID 0000-0002-1215-1493

Funding

Université de Versailles Saint-Quentin-en-Yvelines NA
6 · The paper itself

Abstract

Factor V (FV) Leiden and

Indexed as

Factor VMultiplex Polymerase Chain ReactionPolymorphism, Restriction Fragment LengthProthrombinThrombosisHumansRisk FactorsFactor Vfactor V LeidenProthrombincontamination detectionF2 G20210AFV Leidengenetic risk factorsmolecular diagnosisrestriction fragment length polymorphismvenous thromboembolism

Identifiers

PMID41516174
PMCPMC12785314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.